Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 5/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.47 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | APOBEC3A | P31941 | 3/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.44 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL21143569 | 0.98 | CHRNA7 (0.47) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| SCHEMBL9935176 | 0.90 | KDM4E (0.54) | CHRNA7CHRNB2CHRNA4CTDSP1KDM4E | |
| Bromide SCHEMBL9671965 | 0.90 | CHRNB2 (0.47) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| SCHEMBL9936229 | 0.88 | ALDH1A1 (0.55) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| Bromide SCHEMBL9670755 | 0.88 | CHRNB2 (0.46) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| SCHEMBL18945898 | 0.85 | SIGMAR1 (0.55) | CHRM2CHRM4 | |
| SCHEMBL18917605 | 0.84 | CHRNA7 (0.50) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| SCHEMBL11133958 | 0.83 | ALDH1A1 (0.54) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA | |
| Bromide SCHEMBL11132066 | 0.83 | CTDSP1 (0.51) | CHRNA7CTDSP1LMNAKDM4EAPOBEC3A | |
| Water SCHEMBL18917598 | 0.83 | CHRNA7 (0.49) | CHRNA7CHRNB2CHRNA4CTDSP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108290749-B | Novel synthetic crystalline EMM-28 material, its preparation and use | 埃克森美孚科技工程公司 | 2022-06-24 | — | — | CN | disclosed |
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | CHRNA7 4687/4885CHRNB2 4678/4885CHRNA4 4749/4885 |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | CHRNA7 4687/4885CHRNB2 4678/4885CHRNA4 4749/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | CHRNA7 4687/4885CHRNB2 4678/4885CHRNA4 4749/4885 |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | CHRNA7 4687/4885CHRNB2 4678/4885CHRNA4 4749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.